Suppr超能文献

人 HepG2 肝细胞中的 RNA 测序揭示 PPAR-α 介导胆红素转录组反应性。

RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubin.

机构信息

Center for Hypertension and Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine , Toledo, Ohio.

Department of Pathology, University of Toledo College of Medicine , Toledo, Ohio.

出版信息

Physiol Genomics. 2019 Jun 1;51(6):234-240. doi: 10.1152/physiolgenomics.00028.2019. Epub 2019 May 10.

Abstract

Bilirubin is a potent antioxidant that reduces inflammation and the accumulation of fat. There have been reports of gene responses to bilirubin, which was mostly attributed to its antioxidant function. Using RNA sequencing, we found that biliverdin, which is rapidly reduced to bilirubin, induced transcriptome responses in human HepG2 hepatocytes in a peroxisome proliferator-activated receptor (PPAR)-α-dependent fashion (398 genes with >2-fold change; false discovery rate < 0.05). For comparison, a much narrower set of genes demonstrated differential expression when PPAR-α was suppressed via lentiviral shRNA knockdown (23 genes). Gene set enrichment analysis revealed the bilirubin-PPAR-α transcriptome mediates pathways for oxidation-reduction processes, mitochondrial function, response to nutrients, fatty acid oxidation, and lipid homeostasis. Together, these findings suggest that transcriptome responses from the generation of bilirubin are mostly PPAR-α dependent, and its antioxidant function regulates a smaller set of genes.

摘要

胆红素是一种有效的抗氧化剂,可减轻炎症和脂肪堆积。已有研究报道胆红素可引发基因应答,这主要归因于其抗氧化功能。我们通过 RNA 测序发现,胆红素的快速还原产物——胆绿素,以过氧化物酶体增殖物激活受体 (PPAR)-α 依赖的方式诱导人 HepG2 肝细胞的转录组应答(2 倍变化以上的基因有 398 个;错误发现率 < 0.05)。相比之下,通过慢病毒 shRNA 敲低抑制 PPAR-α 时,差异表达的基因数量要少得多(23 个)。基因集富集分析显示,胆红素-PPAR-α 转录组介导氧化还原过程、线粒体功能、对营养物质的反应、脂肪酸氧化和脂质动态平衡的途径。总之,这些发现表明,胆红素生成的转录组应答主要依赖于 PPAR-α,而其抗氧化功能则调控着一小部分基因。

相似文献

6
Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.缺氧通过 HIF-2α/PPARα 通路加重非酒精性脂肪性肝病。
Am J Physiol Endocrinol Metab. 2019 Oct 1;317(4):E710-E722. doi: 10.1152/ajpendo.00052.2019. Epub 2019 Aug 20.

引用本文的文献

1
Bilirubin - new insights into an old molecule.胆红素——对一种古老分子的新见解。
Biochem Med (Zagreb). 2025 Jun 15;35(2):020501. doi: 10.11613/BM.2025.020501. Epub 2025 Apr 15.
2
Bilirubin metabolism in relation to cancer.胆红素代谢与癌症的关系。
Front Oncol. 2025 Apr 11;15:1570288. doi: 10.3389/fonc.2025.1570288. eCollection 2025.

本文引用的文献

2
Bilirubin, a Cardiometabolic Signaling Molecule.胆红素,一种心脏代谢信号分子。
Hypertension. 2018 Oct;72(4):788-795. doi: 10.1161/HYPERTENSIONAHA.118.11130.
3
Bilirubin, a new therapeutic for kidney transplant?胆红素,治疗肾移植的新方法?
Transplant Rev (Orlando). 2018 Oct;32(4):234-240. doi: 10.1016/j.trre.2018.06.003. Epub 2018 Jun 28.
6
Biliverdin reductase and bilirubin in hepatic disease.胆红素还原酶与肝胆疾病中的胆红素
Am J Physiol Gastrointest Liver Physiol. 2018 Jun 1;314(6):G668-G676. doi: 10.1152/ajpgi.00026.2018. Epub 2018 Mar 1.
7
Bilirubin in the Liver-Gut Signaling Axis.胆红素在肝脏-肠道信号轴中的作用。
Trends Endocrinol Metab. 2018 Mar;29(3):140-150. doi: 10.1016/j.tem.2018.01.002. Epub 2018 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验